Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, 5th floor, Dr, Shariati Hospital, North Kargar Ave, 14114 Tehran, Iran.
Daru. 2012 Aug 28;20(1):10. doi: 10.1186/2008-2231-20-10.
BACKGROUND & THE PURPOSE OF THE STUDY: Prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide. To reduce its risk and progression, preventive strategies are needed. Vitamin supplementation such as vitamin D is one of the strategies. This study was designed to investigate the effect of injection of vitamin D on insulin resistance and anthropometric parameters in T2DM.
This randomized double-blind clinical trial was conducted with 42 diabetic patients in two groups; intervention group with single intramuscular injection of 300,000 International Unit (IU) of vitamin D3 and the placebo group. After recording demographic and anthropometric factors (waist circumference, blood pressure and body mass index), fasting blood samples was taken for measurement of blood glucose, 25-hydroxyvitamin D3 (25-OHD3), insulin, glycosylated hemoglobin A1c (HbA1c) and estimation of Homeostasis Model Assessment Index (HOMA) in two times; before study and after three months.
Two groups had similar baseline characteristics (each group = 21 subjects). Three months after vitamin D injection, HbA1c, anthropometric factors and HOMA index in intervention group stayed constant, however, serum 25- OHD3 was significantly increased (p = 0.007).
The present data is not convincing and further studies with large sample sizes are needed to show the definite effect of injection of vitamin D on control of diabetes and its risk.
背景与研究目的:2 型糖尿病(T2DM)的患病率在全球范围内呈上升趋势。为了降低其风险和进展,需要采取预防策略。维生素补充剂,如维生素 D,就是其中一种策略。本研究旨在探讨维生素 D 注射对 T2DM 患者胰岛素抵抗和人体测量参数的影响。
这是一项随机、双盲临床试验,共纳入 42 例糖尿病患者,分为两组:干预组给予单次肌肉注射 30 万国际单位(IU)维生素 D3,安慰剂组给予安慰剂。记录人口统计学和人体测量学参数(腰围、血压和体重指数)后,分别在研究前和 3 个月时采集空腹血样,用于测量血糖、25-羟维生素 D3(25-OHD3)、胰岛素、糖化血红蛋白 A1c(HbA1c)和稳态模型评估指数(HOMA)。
两组患者的基线特征相似(每组 21 例)。维生素 D 注射 3 个月后,干预组的 HbA1c、人体测量学参数和 HOMA 指数保持不变,但血清 25-OHD3 显著增加(p=0.007)。
目前的数据尚无说服力,需要进一步进行更大样本量的研究,以明确维生素 D 注射对糖尿病控制及其风险的影响。